UniProt ID | SKIV2_HUMAN | |
---|---|---|
UniProt AC | Q15477 | |
Protein Name | Helicase SKI2W | |
Gene Name | SKIV2L | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1246 | |
Subcellular Localization | Nucleus . Cytoplasm . | |
Protein Description | Helicase; has ATPase activity. Component of the SKI complex which is thought to be involved in exosome-mediated RNA decay and associates with transcriptionally active genes in a manner dependent on PAF1 complex (PAF1C).. | |
Protein Sequence | MMETERLVLPPPDPLDLPLRAVELGCTGHWELLNLPGAPESSLPHGLPPCAPDLQQEAEQLFLSSPAWLPLHGVEHSARKWQRKTDPWSLLAVLGAPVPSDLQAQRHPTTGQILGYKEVLLENTNLSATTSLSLRRPPGPASQSLWGNPTQYPFWPGGMDEPTITDLNTREEAEEEIDFEKDLLTIPPGFKKGMDFAPKDCPTPAPGLLSLSCMLEPLDLGGGDEDENEAVGQPGGPRGDTVSASPCSAPLARASSLEDLVLKEASTAVSTPEAPEPPSQEQWAIPVDATSPVGDFYRLIPQPAFQWAFEPDVFQKQAILHLERHDSVFVAAHTSAGKTVVAEYAIALAQKHMTRTIYTSPIKALSNQKFRDFRNTFGDVGLLTGDVQLHPEASCLIMTTEILRSMLYSGSDVIRDLEWVIFDEVHYINDVERGVVWEEVLIMLPDHVSIILLSATVPNALEFADWIGRLKRRQIYVISTVTRPVPLEHYLFTGNSSKTQGELFLLLDSRGAFHTKGYYAAVEAKKERMSKHAQTFGAKQPTHQGGPAQDRGVYLSLLASLRTRAQLPVVVFTFSRGRCDEQASGLTSLDLTTSSEKSEIHLFLQRCLARLRGSDRQLPQVLHMSELLNRGLGVHHSGILPILKEIVEMLFSRGLVKVLFATETFAMGVNMPARTVVFDSMRKHDGSTFRDLLPGEYVQMAGRAGRRGLDPTGTVILLCKGRVPEMADLHRMMMGKPSQLQSQFRLTYTMILNLLRVDALRVEDMMKRSFSEFPSRKDSKAHEQALAELTKRLGALEEPDMTGQLVDLPEYYSWGEELTETQHMIQRRIMESVNGLKSLSAGRVVVVKNQEHHNALGVILQVSSNSTSRVFTTLVLCDKPLSQDPQDRGPATAEVPYPDDLVGFKLFLPEGPCDHTVVKLQPGDMAAITTKVLRVNGEKILEDFSKRQQPKFKKDPPLAAVTTAVQELLRLAQAHPAGPPTLDPVNDLQLKDMSVVEGGLRARKLEELIQGAQCVHSPRFPAQYLKLRERMQIQKEMERLRFLLSDQSLLLLPEYHQRVEVLRTLGYVDEAGTVKLAGRVACAMSSHELLLTELMFDNALSTLRPEEIAALLSGLVCQSPGDAGDQLPNTLKQGIERVRAVAKRIGEVQVACGLNQTVEEFVGELNFGLVEVVYEWARGMPFSELAGLSGTPEGLVVRCIQRLAEMCRSLRGAARLVGEPVLGAKMETAATLLRRDIVFAASLYTQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MMETERLVLPP ----CCCCEECCCCC | 25.71 | 21406692 | |
84 | Ubiquitination | SARKWQRKTDPWSLL CHHHHCCCCCCCHHH | 42.03 | - | |
131 | Phosphorylation | TNLSATTSLSLRRPP CCCCCEEEEEECCCC | 16.17 | 22167270 | |
133 | Phosphorylation | LSATTSLSLRRPPGP CCCEEEEEECCCCCC | 21.43 | 22167270 | |
181 | Ubiquitination | EEEIDFEKDLLTIPP HHHCCCCHHHCCCCC | 54.38 | - | |
185 | Phosphorylation | DFEKDLLTIPPGFKK CCCHHHCCCCCCCCC | 38.44 | - | |
191 | Ubiquitination | LTIPPGFKKGMDFAP CCCCCCCCCCCCCCC | 55.09 | - | |
192 | Ubiquitination | TIPPGFKKGMDFAPK CCCCCCCCCCCCCCC | 58.15 | - | |
241 | Phosphorylation | PGGPRGDTVSASPCS CCCCCCCCCCCCCCC | 21.13 | 23927012 | |
243 | Phosphorylation | GPRGDTVSASPCSAP CCCCCCCCCCCCCCC | 25.73 | 30266825 | |
245 | Phosphorylation | RGDTVSASPCSAPLA CCCCCCCCCCCCCHH | 20.95 | 19664994 | |
248 | Phosphorylation | TVSASPCSAPLARAS CCCCCCCCCCHHCCC | 35.98 | 30266825 | |
255 | Phosphorylation | SAPLARASSLEDLVL CCCHHCCCCHHHHHH | 29.87 | 22167270 | |
256 | Phosphorylation | APLARASSLEDLVLK CCHHCCCCHHHHHHH | 34.49 | 19664994 | |
266 | Phosphorylation | DLVLKEASTAVSTPE HHHHHHHCCCCCCCC | 20.28 | 28464451 | |
267 | Phosphorylation | LVLKEASTAVSTPEA HHHHHHCCCCCCCCC | 37.82 | 29116813 | |
270 | Phosphorylation | KEASTAVSTPEAPEP HHHCCCCCCCCCCCC | 35.46 | 29116813 | |
271 | Phosphorylation | EASTAVSTPEAPEPP HHCCCCCCCCCCCCC | 20.67 | 22817900 | |
279 | Phosphorylation | PEAPEPPSQEQWAIP CCCCCCCCHHCCCCC | 58.00 | 28102081 | |
290 | Phosphorylation | WAIPVDATSPVGDFY CCCCCCCCCCCCCHH | 29.15 | 28102081 | |
291 | Phosphorylation | AIPVDATSPVGDFYR CCCCCCCCCCCCHHH | 21.22 | 28102081 | |
316 | Ubiquitination | FEPDVFQKQAILHLE CCCCHHHHHHHHHHH | 30.17 | - | |
327 | Phosphorylation | LHLERHDSVFVAAHT HHHHHCCCEEEEEEC | 16.01 | 20873877 | |
334 | Phosphorylation | SVFVAAHTSAGKTVV CEEEEEECCCCCHHH | 18.62 | 28851738 | |
335 | Phosphorylation | VFVAAHTSAGKTVVA EEEEEECCCCCHHHH | 25.75 | 28851738 | |
351 | Ubiquitination | YAIALAQKHMTRTIY HHHHHHHHHCCCEEE | 29.72 | - | |
356 | Phosphorylation | AQKHMTRTIYTSPIK HHHHCCCEEECCHHH | 14.79 | 28787133 | |
358 | Phosphorylation | KHMTRTIYTSPIKAL HHCCCEEECCHHHHH | 10.68 | 26074081 | |
359 | Phosphorylation | HMTRTIYTSPIKALS HCCCEEECCHHHHHC | 24.95 | 26074081 | |
360 | Phosphorylation | MTRTIYTSPIKALSN CCCEEECCHHHHHCC | 13.99 | 26074081 | |
363 | Ubiquitination | TIYTSPIKALSNQKF EEECCHHHHHCCCCH | 46.81 | 21906983 | |
363 | Ubiquitination | TIYTSPIKALSNQKF EEECCHHHHHCCCCH | 46.81 | 21890473 | |
366 | Phosphorylation | TSPIKALSNQKFRDF CCHHHHHCCCCHHHH | 41.91 | 26074081 | |
369 | 2-Hydroxyisobutyrylation | IKALSNQKFRDFRNT HHHHCCCCHHHHHHH | 46.76 | - | |
369 | Ubiquitination | IKALSNQKFRDFRNT HHHHCCCCHHHHHHH | 46.76 | - | |
405 | Phosphorylation | MTTEILRSMLYSGSD CCHHHHHHHHHCCCH | 15.08 | 29396449 | |
408 | Phosphorylation | EILRSMLYSGSDVIR HHHHHHHHCCCHHHH | 11.44 | 29396449 | |
409 | Phosphorylation | ILRSMLYSGSDVIRD HHHHHHHCCCHHHHC | 28.05 | 20068231 | |
411 | Phosphorylation | RSMLYSGSDVIRDLE HHHHHCCCHHHHCCE | 23.82 | 20068231 | |
476 | Phosphorylation | RLKRRQIYVISTVTR HHHHCEEEEEEEECC | 5.38 | - | |
493 | Phosphorylation | PLEHYLFTGNSSKTQ ECCEEEEECCCCCCC | 32.62 | 20860994 | |
496 | Phosphorylation | HYLFTGNSSKTQGEL EEEEECCCCCCCEEE | 34.26 | 20860994 | |
509 | Phosphorylation | ELFLLLDSRGAFHTK EEEEEEECCCCCCCC | 32.36 | 23186163 | |
516 | Ubiquitination | SRGAFHTKGYYAAVE CCCCCCCCHHHHHHH | 36.02 | 21906983 | |
518 | Phosphorylation | GAFHTKGYYAAVEAK CCCCCCHHHHHHHHH | 7.47 | - | |
519 | Phosphorylation | AFHTKGYYAAVEAKK CCCCCHHHHHHHHHH | 9.21 | - | |
525 | 2-Hydroxyisobutyrylation | YYAAVEAKKERMSKH HHHHHHHHHHHHHHH | 41.48 | - | |
525 | Malonylation | YYAAVEAKKERMSKH HHHHHHHHHHHHHHH | 41.48 | 26320211 | |
525 | Ubiquitination | YYAAVEAKKERMSKH HHHHHHHHHHHHHHH | 41.48 | - | |
526 | Ubiquitination | YAAVEAKKERMSKHA HHHHHHHHHHHHHHH | 58.56 | - | |
530 | Phosphorylation | EAKKERMSKHAQTFG HHHHHHHHHHHHHHC | 27.75 | 20068231 | |
531 | Ubiquitination | AKKERMSKHAQTFGA HHHHHHHHHHHHHCC | 33.35 | - | |
535 | Phosphorylation | RMSKHAQTFGAKQPT HHHHHHHHHCCCCCC | 25.48 | 22210691 | |
539 | Acetylation | HAQTFGAKQPTHQGG HHHHHCCCCCCCCCC | 58.13 | 25953088 | |
539 | Ubiquitination | HAQTFGAKQPTHQGG HHHHHCCCCCCCCCC | 58.13 | 21906983 | |
560 | Phosphorylation | VYLSLLASLRTRAQL HHHHHHHHHHHHCCC | 20.53 | 24719451 | |
573 | Phosphorylation | QLPVVVFTFSRGRCD CCCEEEEEECCCCCC | 14.75 | - | |
575 | Phosphorylation | PVVVFTFSRGRCDEQ CEEEEEECCCCCCHH | 30.66 | - | |
597 | Ubiquitination | DLTTSSEKSEIHLFL ECCCCCCHHHHHHHH | 56.17 | - | |
637 | Phosphorylation | RGLGVHHSGILPILK CCCCCCCCCHHHHHH | 16.79 | 25850435 | |
697 | Phosphorylation | RDLLPGEYVQMAGRA HHHCCHHHHHHCCCC | 11.25 | 27642862 | |
714 | Phosphorylation | RGLDPTGTVILLCKG CCCCCCCCEEEEECC | 13.57 | 28857561 | |
720 | Ubiquitination | GTVILLCKGRVPEMA CCEEEEECCCCHHHH | 50.12 | - | |
736 | Ubiquitination | LHRMMMGKPSQLQSQ HHHHHCCCHHHHHHH | 24.49 | - | |
748 | Phosphorylation | QSQFRLTYTMILNLL HHHHHHHHHHHHHHH | 10.02 | 20068231 | |
767 | Ubiquitination | LRVEDMMKRSFSEFP HHHHHHHHHCHHHCC | 37.95 | - | |
769 | Phosphorylation | VEDMMKRSFSEFPSR HHHHHHHCHHHCCCH | 27.83 | 29209046 | |
771 | Phosphorylation | DMMKRSFSEFPSRKD HHHHHCHHHCCCHHC | 39.30 | 29209046 | |
775 | Phosphorylation | RSFSEFPSRKDSKAH HCHHHCCCHHCCHHH | 58.23 | 22115753 | |
777 | Ubiquitination | FSEFPSRKDSKAHEQ HHHCCCHHCCHHHHH | 71.36 | - | |
779 | Phosphorylation | EFPSRKDSKAHEQAL HCCCHHCCHHHHHHH | 34.47 | 23927012 | |
780 | Ubiquitination | FPSRKDSKAHEQALA CCCHHCCHHHHHHHH | 64.99 | 21906983 | |
791 | Ubiquitination | QALAELTKRLGALEE HHHHHHHHHHCCCCC | 59.24 | 21906983 | |
802 | Phosphorylation | ALEEPDMTGQLVDLP CCCCCCCCCCEECCH | 29.20 | 23403867 | |
837 | Ubiquitination | MESVNGLKSLSAGRV HHHHCCHHHCCCCCE | 51.23 | 21906983 | |
863 | Phosphorylation | LGVILQVSSNSTSRV EEEEEEEECCCCCCE | 15.73 | 20860994 | |
864 | Phosphorylation | GVILQVSSNSTSRVF EEEEEEECCCCCCEE | 35.62 | 20860994 | |
866 | Phosphorylation | ILQVSSNSTSRVFTT EEEEECCCCCCEEEE | 29.70 | 20860994 | |
879 | Ubiquitination | TTLVLCDKPLSQDPQ EEEEEECCCCCCCCC | 47.03 | - | |
882 | Phosphorylation | VLCDKPLSQDPQDRG EEECCCCCCCCCCCC | 40.85 | 23663014 | |
892 | Phosphorylation | PQDRGPATAEVPYPD CCCCCCCCCCCCCCC | 26.87 | 21406692 | |
897 | Phosphorylation | PATAEVPYPDDLVGF CCCCCCCCCCCCCEE | 25.19 | 21406692 | |
905 | Ubiquitination | PDDLVGFKLFLPEGP CCCCCEEEEECCCCC | 32.19 | - | |
919 | Ubiquitination | PCDHTVVKLQPGDMA CCCCEEEECCCCCHH | 36.75 | - | |
930 | Phosphorylation | GDMAAITTKVLRVNG CCHHHEEEEEEEECH | 17.03 | 19413330 | |
931 | Ubiquitination | DMAAITTKVLRVNGE CHHHEEEEEEEECHH | 30.53 | - | |
939 | Ubiquitination | VLRVNGEKILEDFSK EEEECHHHHHHHHHH | 54.73 | - | |
945 | Phosphorylation | EKILEDFSKRQQPKF HHHHHHHHHHCCCCC | 38.97 | 27542207 | |
946 | Ubiquitination | KILEDFSKRQQPKFK HHHHHHHHHCCCCCC | 54.97 | - | |
953 | Ubiquitination | KRQQPKFKKDPPLAA HHCCCCCCCCCCHHH | 63.49 | - | |
954 | Ubiquitination | RQQPKFKKDPPLAAV HCCCCCCCCCCHHHH | 77.82 | - | |
991 | Ubiquitination | PVNDLQLKDMSVVEG CCCCCCCCCCCHHHC | 38.12 | 21906983 | |
994 | Phosphorylation | DLQLKDMSVVEGGLR CCCCCCCCHHHCCHH | 32.90 | 28857561 | |
1004 | Ubiquitination | EGGLRARKLEELIQG HCCHHHHHHHHHHHH | 60.30 | - | |
1017 | Phosphorylation | QGAQCVHSPRFPAQY HHCCCCCCCCCCHHH | 9.43 | 20873877 | |
1026 | Ubiquitination | RFPAQYLKLRERMQI CCCHHHHHHHHHHHH | 40.33 | - | |
1035 | Ubiquitination | RERMQIQKEMERLRF HHHHHHHHHHHHHHH | 61.73 | - | |
1075 | Ubiquitination | VDEAGTVKLAGRVAC CCCCCCEEECHHHHH | 32.24 | 21906983 | |
1225 | Ubiquitination | GEPVLGAKMETAATL CCCCCCCCHHHHHHH | 35.16 | 21906983 | |
1228 | Phosphorylation | VLGAKMETAATLLRR CCCCCHHHHHHHHHH | 20.35 | 20068231 | |
1231 | Phosphorylation | AKMETAATLLRRDIV CCHHHHHHHHHHHHH | 24.70 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SKIV2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SKIV2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SKIV2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CD11A_HUMAN | CDK11A | physical | 15231747 | |
TSSK2_HUMAN | TSSK2 | physical | 21988832 | |
EXOS4_HUMAN | EXOSC4 | physical | 15231747 | |
XRN1_HUMAN | XRN1 | physical | 15231747 | |
RSMB_HUMAN | SNRPB | physical | 15231747 | |
MPPA_HUMAN | PMPCA | physical | 15231747 | |
GLT13_HUMAN | GALNT13 | physical | 15231747 | |
WDR1_HUMAN | WDR1 | physical | 15231747 | |
THOC4_HUMAN | ALYREF | physical | 26344197 | |
CBS_HUMAN | CBS | physical | 26344197 | |
RAN_HUMAN | RAN | physical | 26344197 | |
TTC37_HUMAN | TTC37 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
614602 | Trichohepatoenteric syndrome 2 (THES2) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-256, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245 AND SER-256, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245 AND SER-256, ANDMASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-256, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-256 AND SER-366, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245 AND SER-256, ANDMASS SPECTROMETRY. |